A new model to predict benign histology in residual retroperitoneal masses after chemotherapy in nonseminoma
Background Postchemotherapy retroperitoneal lymph node dissection (pcRPLND) is
indicated in testicular cancer patients with normalised or plateaued serum tumour markers
and residual retroperitoneal lesions> 1 cm. Challenges remain in predicting
postchemotherapy residual mass (pcRM) histology, which may lead to unnecessary surgery.
Objective To develop an accurate model to predict pcRM histology in patients with
nonseminomatous germ cell tumours (NSGCTs). Design, setting, and participants A …
indicated in testicular cancer patients with normalised or plateaued serum tumour markers
and residual retroperitoneal lesions> 1 cm. Challenges remain in predicting
postchemotherapy residual mass (pcRM) histology, which may lead to unnecessary surgery.
Objective To develop an accurate model to predict pcRM histology in patients with
nonseminomatous germ cell tumours (NSGCTs). Design, setting, and participants A …
以上显示的是最相近的搜索结果。 查看全部搜索结果